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Thesis Abstract 
 Humans express the APOBEC3 family of proteins to defend against endogenous 
and exogenous DNA pathogens. APOBEC3 proteins display significant activity towards 
HIV-1 through incorporation into budding viral particle and interacting with HIV’s RNA 
genome. In order to stably integrate into the human genome, HIV reverse transcribes the 
single stranded RNA genome into a double stranded DNA genome through a single 
stranded DNA intermediate. Once bound to the transient single stranded viral DNA 
intermediate, APOBEC3 proteins deaminate cytidines to uridines. Transcription over the 
resulting mutations results in G to A transversions in the coding sequence of the virus and 
non-functional gene products. APOBEC3 proteins are highly active on the single 
stranded DNA intermediate but lack catalytic activity on cytidines present in the viral 
RNA.  
APOBEC3G is the most potent of these innate viral mutagens and selectively 
targets tri-cytidine hotspot motifs in viral genome intermediates. When I began my thesis 
research, the effects of A3G mutagenesis had been extensively studied but the structural 
interactions with single stranded DNA and the mechanism of RNA exclusion were 
unknown. My thesis research helped identify the amino acid responsible for pH 
dependent effects on substrate binding. The identification of this residue allowed for the 
development of a pH insensitive variant of A3G that provided indirect evidence for a 
reduced pH in the viral capsid during the initiation of reverse transcription. These results, 
along with the kinetic characterization of A3Gctd and determination of the substrate 
factors crucial for deamination, are described in Chapter 2. 
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 In chapter 3, I continued to explore the effects of this pH dependent increase in 
binding affinity. I utilized NMR spectroscopy to identify the structural interactions of 
catalytic substrate binding. By generating a structurally stable but catalytically inactive 
mutant, I was able to identify differences between substrate interactions. This mutant also 
allowed me to explore structural interactions involved in substrate recognition and RNA 
exclusion. This lead to the identification of a novel substrate and a ribose sugar pucker 
dependent mechanism for target discrimination.  
The role of APOBEC3 proteins in retroviral restriction as well as their connection 
to several types of cancer makes them a prime target for therapeutic interventions. My 
thesis research in trying to understand the structural and mechanistic components of the 
APOBEC3/DNA interaction provides information that may be useful in the development 
of treatments targeting this family of proteins.  
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Chapter 1 - Introduction  
APOBEC3G and its interactions with oligonucleotides 
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1.1. Synopsis 
During viral infections the body has two distinct layers of defense. The innate 
immune system is constantly present and responds immediately to viral infections while 
the adaptive immune system takes longer to respond to infection but is specifically 
targeted at the invading virus. Human APOBEC3G (A3G) is involved in the innate 
immune and as such is present in several types of cells at all times. A3G works by 
tagging along with the virus as it moves from cell to cell and analogous to a ‘Trojan 
Horse’ springs forth from the virus mutating the viral DNA which prevents the virus from 
being able to effectively infect new cells. Much of the mutational activity stems from 
A3G’s ability to bind viral DNA in the proper catalytic orientation to allow A3G to 
mutate the DNA. The aim of this review is to compile the most current knowledge in the 
field as to how A3G accomplishes these goals and what physical characteristics are 
relevant to successful mutation.  
 
1.2. Background 
Human APOBEC3G (A3G) is a member of a family of cytidine deaminases 
including AID, APOBEC1, APOBEC2, APOBEC3A, APOBEC3B, APOBEC3C, 
APOBEC3DE, APOBEC3F, APOBEC3G, APOBEC3H, and APOBEC4 which are 
involved in a range of cellular processes including antibody diversification, inhibition of 
transposable DNA elements and innate immunity. APOBEC3 proteins can be either 
single-domain (A3A, A3C, and A3H) or double-domain (A3B, A3DE, A3F, and A3G) 
proteins with one or two zinc coordinating domains respectively. A3G specifically 
demonstrates restrictive activity against HIV-1 in the absence of the viral accessory 
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protein Vif. A3G has been shown to be capable of retroviral restriction through both 
deaminase dependent and independent mechanisms of action [1]–[6]. However, A3G’s 
HIV-1 restrictive capacity is dominated by the deamination dependent mechanism [5]. 
A3G exhibits a context specific deamination target first seen in characteristic GG->GA 
hypermutation patterns on the HIV-1 plus strand in infected patients. Further insight into 
deamination preferences in cell lines infected with Vif-deficient HIV-1 indicated a 5’ 
CCC 3’ target site with the underlined C indicating the preferred deamination site [1]–[3]. 
Extensive deamination of the viral genome introduces premature stop codons as well as 
generating missense mutations genome-wide while sub-lethal levels of mutation are 
thought to contribute to viral escape of host defenses. Recent studies have focused on the 
physical interactions of A3G with ssDNA in an attempt to understand the mechanism of 
A3G binding and target specificity.  
 
1.3. APOBEC3 family 
The human APOBEC3G protein belongs to a family of seven polynucleotide 
cytidine deaminases (A3A-A3H) [7], [8]. The APOBEC3 family share common catalytic 
mechanism, context dependent deamination preferences, and structure. APOBEC3 
proteins deaminate cytidines in single stranded DNA polynucleotides to non-native 
uridine residues. The APOBEC family of proteins is present in all placental mammal and 
functions to restrict both endogenous transposable DNA elements and exogenous DNA 
viruses. The mammalian APOBEC3 locus in particular displays significant copy number 
variation and hallmarks of positive selection as a result of long term competition with 
viral pathogens [9]–[15]. The human APOBEC3 locus is organized linearly on 
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chromosome 22 [8]. The characteristic feature of APOBEC3 proteins are their zinc-
coordinating domains (Z-domains), containing the conserved H-X-E-X25-31-P-C-X2-4-C 
zinc-binding motif (Fig 1.1). The APOBEC3 family is comprised of three evolutionarily 
distinct Z-domains (Z1, Z2, Z3), varying in amino acid composition within the zinc-
binding motifs. Z1 and Z2 domains contain SW-S/T-C-X2-4-C motifs while Z3 domains 
contain a TW-S-C-X2-C motif. Z1 and Z2 domains are distinguished by H-X-E-X6-V/I 
and H-X-W-X5-W-F motifs, respectively [11]. 
  
 
Fig. 1.1. APOBEC3 locus organization. APOBEC3 proteins are organized linearly on 
chromosome 22. Individual APOBEC3 protein compositions are shown. Each distinct Z-
domain is indicated with a colored arrow representing evolutionary lineage, Z1 (green), 
Z2 (yellow), and Z3 (blue). (Adapted from LaRue et al. Journal of Virology 83(2) 2009, 
494-497) 
 
Cytidine deamination is highly context dependent with minimal target sites 
consisting of a dinucleotide 5’-XC motif, where the 5’-X is either another cytidine (A3G) 
or thymidine (A3A, A3B, A3C, A3DE, A3F, A3H) [16]. Cytidine deamination takes 
place through a conserved mechanism of nucleophilic zinc mediated hydrolysis of the 
amine group at the 4-position of the pyrimidine ring resulting in the replacement of the 
amine group with a carbonyl moiety. Outside of the minimal 5’-XC motif required for 
catalysis, APOBEC3 proteins require an extended polynucleotide containing a minimum 
of five nucleotides with three nucleotides preceding the target cytidine and one nucleotide 
following [17]. The composition of these flanking nucleotides result in different catalytic 
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rates (discussed later) but the presence of these flanking nucleotides is required for 
catalysis.  
 
1.4. Structure 
APOBEC3 proteins contain either one (A3A, A3C, and A3H) or two (A3B, 
A3DE, A3F, A3G) conserved zinc-coordinating domains. In the case of the double 
domain APOBEC3s the domains are likely connected by a flexible linker. The structures 
of several isolated APOBEC3 domains have been solved by X-ray crystallography or 
NMR (Table 1.1).  
 
Table 1.1. Structures of APOBEC family members 
 
Protein Method Domain Reference 
APOBEC2 X-ray Single Domain 2NYT [18] 
APOBEC2 NMR Single Domain 2RPZ [19] 
APOBEC3A NMR Single Domain 2M65 [20] 
APOBEC3A X-ray Single Domain 4XXO [21] 
APOBEC3C X-ray Single Domain 3VOW [22] 
APOBEC3F X-ray C-Terminal 4IOU [23] 
APOBEC3G NMR C-Terminal 2KBO [24] 
APOBEC3G NMR C-Terminal 2KEM [25] 
APOBEC3G X-ray C-Terminal  3V4K [26] 
APOBEC3G NMR N-Terminal 2MZZ [27] 
 
Based upon the currently available structural information, APOBEC3 proteins 
adopt a conserved core fold consisting of six alpha-helices and five beta-strands (Fig. 
1.2). The five beta-strands form an extended beta-sheet that comprises the hydrophobic 
core of the protein with the alpha-helices arranged around the core sheet. Unique to 
APOBEC3G is the presence of the non-continuous β2 sheet. The α2 and α3 helices 
contain the conserved H-X-E-X25-31-P-C-X2-4-C motif required for zinc coordination 
6 
 
(numbering based on N to C terminal locations of secondary structure elements). Loops 
of varying length and composition connect the secondary structure elements and have 
been implicated in substrate binding and target selection. These loops comprise the 
majority of the predicted ssDNA binding interface. The non-catalytic N-terminal domain 
of APOBEC3G structure displays the same core fold of the previously solved APOBEC 
catalytic domains. However, the α2 helix is shortened causing a significant difference in 
orientation resulting in a repositioning of the pseudo-catalytic glutamate residue away 
from the active site and loss of catalytic activity [27]. 
 
Fig. 1.2. Structural comparison of APOBEC family. Representative structures of 
APOBEC domains. Secondary structural elements ordered from N to C-terminus α1-β1-
β2-(β2’)*-α2-β3-α3-β4-α4-β5-α5-α6. *β2’ only present in A3Gctd.  
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1.5. APOBEC3s and innate immunity to HIV-1 
The most well characterized activity of APOBEC3 proteins is their ability to 
restrict HIV-1 viral infection in the absence of the viral Vif (viral infectivity factor) 
protein ([1]–[6]). During Vif-deficient HIV-1 infection, restrictive APOBEC3 proteins 
(A3DE, A3F, A3G, and A3H) are incorporated into budding viral particles (Fig. 1.3). 
Following viral maturation, virion binding to target cells, fusion with the target cell 
membrane, and injection of the viral capsid into the cytoplasm, HIV utilizes the viral 
reverse transcriptase to initiate the process of reverse transcription from the RNA genome 
which results in a negative sense ssDNA genome intermediate. The restrictive APOBEC3 
proteins incorporated into the virion bind and deaminate target cytidines in this ssDNA 
intermediate. Subsequent transcription of the negative sense intermediate incorporates 
these mutations into the coding sequence of virus resulting in missense mutations in viral 
proteins as well as premature stop codons. This resulting hypermutation phenotype can 
render the virus incapable of further rounds of replication thus restricting virus effectively 
dead. Only APOBEC3 proteins from the initial producer cell, and not the APOBEC3 
repertoire of the target cell, have access to the viral ssDNA.  
In a Vif-proficient virus, the presence of the Vif protein abrogates APOBEC3 
function. Vif recruits the endogenous proteins CBFβ, Elongin B, Elongin C, RBX1, and 
Cul5 into an E3 ligase complex that binds restrictive APOBEC3 proteins resulting in 
their polyubiquitination and subsequent degradation by the proteasome. This effectively 
limits the pool of resident restrictive APOBEC3 proteins and prevents their incorporation 
into the budding viral particles and allows for efficient viral replication.  
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Fig. 1.3. Model for restrictive APOBEC3 function during the HIV-1 viral life cycle. 
(Adapted from Harris and Dudley, Virology 479-480 2015, 131–145) 
 
1.6. APOBEC3G ssDNA binding interface 
The catalytic activity of APOBEC3G comes exclusively from the C-terminal 
(CD-2) domain with the N-terminal (CD-1) domain assisting in DNA binding. The 
specificity of this binding is directly related to the ability of A3G to restrict viral 
replication through mutation. A3G exhibits a strong directionality in deamination 
preference stemming from a preferred orientation of the 5’ CCC 3’ target motif 
(underlined C indicates target deamination cytidine). Two independent orientations have 
been postulated for DNA binding to A3G [3], [28]. Understanding which of these two 
binding interfaces is accurate gives insight into A3G’s mechanism and target cytosine 
positioning. A3G NMR and X-ray structures along with molecular modelling of the 
A3G-ssDNA complex display two potential DNA binding interfaces [25], [28], [29]. 
Unlike other DNA binding proteins, which tend to have positively charged surfaces that 
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make contact with the phosphate backbone of DNA, A3G binding interfaces direct the 
DNA into a negatively charged groove with several positively charged residues along the 
brim of the channel. One potential binding surface runs parallel to the parallel five beta 
sheet core fold falling between the alpha 1 and alpha 2 helices making contacts with the 
alpha0-beta1 loop (AC1 loop). Residues located in the AC1 loop and the evolutionarily 
conserved beta3-alpha2 loop appear to be critical for effectively positioning the substrate 
recognition sequence for deamination as evidenced by alanine scanning mutations at 
R213, R215, W285, R313, or R320 that either severely attenuate or eliminate 
deamination activity (Fig. 1.4, left) [29]. Several of these residues lie in a hydrogen 
bonding network which stabilize the contacts between AC1 and the β3-α2 loop 
positioning a required W285 residue so that it points into the binding groove allowing for 
potential aromatic ring stacking with DNA and RNA bases [30].  
 
Fig. 1.4. A3Gctd-2K3A deamination mutants and potential binding orientations. 
Residues that result in significantly reduce mutation frequencies are indicated on the 
structure of A3Gctd-2K3A in red (left) [29]. Predicted binding orientation of ssDNA on 
A3Gctd (right), yellow strand indicates ‘brim’ binding orientation, blue strand indicates 
‘kink’ binding orientation.  
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Computer simulation of the A3G-DNA binding interface indicates that the 5’ end 
of ssDNA is directed away from the loop region and the 3’ end extends into the groove 
making contact with the catalytic E259 residue [29]. This orientation requires the flipping 
out of the target cytidine residue in order for catalytically necessary contact to be made as 
has been seen previously in the TadA adenosine deaminase protein [29], [31]. 
Simulations also indicate extensive contact between H257 and the cytidine residue 5’ of 
the target C. Chemical shift perturbations of this residue have been seen in both the wild-
type and 2K3A mutant proteins upon addition of ssDNA. Another potential interaction 
interface extends from the same 5’ contacts with residues R313 and R320 which then 
exhibits a 45 degree kink at the catalytic residue, possibly correlated with the base flip 
out predicted for catalysis [30], with the 3’ tail again extending past the groove between 
alpha1 and alpha2 towards AC loops 1 & 3 (Fig. 1.4, right) [28]. All the current data 
available from NMR chemical shift analysis is unable to distinguish between these two 
conformations as both conformations have potential contacts at a majority of the shifted 
residues depending on base specific orientation in the recognition sequence. Co-
crystallization or a more targeted NMR approach is required to further elucidate the 
A3G-DNA interface.  
 
1.7. Target Site Recognition  
Efficiently locating specific target sequences in long stretches of nucleotides is 
crucial for A3G to effectively restrict viral replication. Once the target sequence is 
located it must also be deaminated and then released so that the enzyme may acquire 
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another target. In vitro analysis using purified A3G and short oligonucleotides containing 
the target triple cytidine site also revealed the impact of the 5’ and 3’ flanking nucleotides 
on deaminase efficiency.  Adenosine is the preferred residue in both the 5’ and 3’ 
position with a more pronounced effect when located at the 3’ position as these residues 
extend into the core of the protein and will make considerably more contacts than the 5’ 
end. This effect does not exhibit a general purine specificity as guanidine substitutions at 
these positions also create a two to three-fold reduction in the specific activity of the 
protein [32]. Further examination of the active site through nucleoside analogs 
highlighted specific aspects of the 5’ and 3’ nucleotides surrounding the target cytidine 
that are important for target recognition. Paramount among these interactions are the 3 
and 4 positions in the purine ring of the cytidine at the -1 position. Substrate analogs that 
maintain the highest levels of activity contain hydrogen bond acceptors at ring position 3 
and acceptors at position 4. These electrostatic interactions, potentially mediated through 
tyrosine 315, likely aid in the positioning of the target C for efficient catalysis [33].  
Interestingly, a wholesale swap of the beta4-alpha4 loop of A3G (I314-Q321) with the 
homologous loop in A3F (L306-Q315) changes target sequence specificity from CCC 
(A3G) to TTC (A3F) indicating that these residues are solely responsible for mediating 
important 5’ DNA contacts [34]. However, without high resolution structural information 
on the A3G-DNA complex there is no way to conclusively determine the protein residues 
responsible for these interactions.  
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1.8. Single Stranded Polynucleotide Binding  
A3G exhibits stringent requirements in the locating and positioning of the DNA 
substrate for catalysis, the opposite is true of general single stranded polynucleotide 
binding. A3G is capable of binding to both ssDNA and ssRNA with a higher affinity for 
ssRNAs. While these ssRNAs are responsible for A3G incorporation into budding virions 
[35]–[39] they inhibit A3G catalytic activity [38]. This activity is restored both in vitro 
and in vivo through RNAse digestion of the inhibitory RNAs.  Full length A3G is capable 
of non-specifically binding ssDNA longer than 9nt regardless of base content or the 
presence of the target motif. The kD across a range of 10-69nt long ssDNA is also 
constant at 50nM for full length A3G in contrast with deamination efficiency which 
shows a drastic decrease from full deamination with 69nt ssDNA to ~10% at 10nt 
ssDNA. This indicates that DNA binding is not the sole factor in determining 
deamination efficiency [32].  
 
1.9. A3G Exhibits Locational/Contextual Differential Deamination Rates  
 A3G deamination rates on DNA substrates containing target motifs with varying 
distances from the 3’ end show a strong location dependence with a 3’ -> 5’ deamination 
polarity. This coincides with the model of random ssDNA binding followed by local 
scanning with a preferred deamination orientation. A3G specific activity on ssDNAs with 
target motifs less than 30nt from the 3’ end show a marked reduction in deamination 
efficiency compared to identical target motifs greater than 30nt away [40]. The 30nt dead 
zone is likely a region required for binding of the N-terminal non-catalytic domain in 
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order to facilitate the catalytically active orientation. In concert with the 3’ -> 5’ 
locational dependent deamination rates A3G shows a distinct 3’ -> 5’ pattern in the order 
of deamination within a target 5’-CCC-3’ motif [3], [32]. The second and third cytidines 
in the target sequence are deaminated at markedly different rates in vitro. The 3’ cytidine 
is fully deaminated in solution with 10-fold excess target DNA in less than 30 minutes 
while the middle cytidine is deaminated 20 times slower with the 5’ C completely 
retained. The functional implication of this deamination order is the creation of premature 
stop codons when the preferred target CCCA sequence is in frame. Deamination of the 3’ 
C in this context changes an in frame tryptophan codon (TGG) on the plus strand to a 
stop codon (TAG). Further deamination of the middle C maintains this in frame stop 
codon (TAA) [28]. Generation of these stop codons, in concert with non-sense mediated 
decay initiated by extensive deamination, in part explain why A3G is so effective in 
restricting HIV-1 infection. This combination of activity gradients along with the target 
sequence work together in the context of viral replication to efficiently deaminate the 
short lived ssDNA intermediate following RNAse digestion of viral RNA.   
 
1.10. Oligomerization 
APOBEC3G has been shown to exist in a range of oligomeric forms ranging from 
monomers to high molecular mass aggregates with the oligomeric composition being 
implicated in viral restriction, DNA binding, and catalytic efficiency [32], [40]–[42]. 
Until recently the predicted structural organization of A3G oligomers was based on the 
crystal structure of the single domain APOBEC2 (A2) protein. A2 crystallized as a 
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homotetramer with the asymmetric unit being a dimer of dimers in an elongated 
conformation atypical of other characterized human cytidine deaminases which formed 
square shaped tetramers [43]. However, the A2 crystal structure utilized a truncated 
version of A2 which lacked the N-terminal 40 residues. A recent solution NMR of the 
full length A2 protein calls the validity of using the A2 crystal structure as a model for 
the double domain deaminases of the APOBEC3 family into question. The full length 
solution structure containing the N-terminal extension positions these residues over the 
β2-β2 dimer contacts seen in the crystal structure. In addition to the physical obstruction 
of the predicted binding interface additional biochemical data shows A2 to be a monomer 
in solution [44]. This coincides with an extended structure of the A3G C-terminal domain 
in which the alpha1 helix is fully formed to stabilize the core fold of the protein with part 
of the alpha0 helix present and extending into the interface predicted from the A2 
structure [25]. In combination with the discontinuous nature of the beta2 strand of A3G 
these data make the idea of the A2 β2-β2 “rib cage” model of the full length protein 
unlikely. An extended full length structure has been postulated from the NMR data and 
appears to be corroborated in SAXS data showing an extended envelope [25], [45]. In the 
absence of a high resolution structure of a full length double domain APOBEC3 protein 
the exact nature of the monomer and oligomers remains unclear.  
Regardless of the exact physical nature of the monomeric and oligomeric forms of 
APOBEC3G there is still extensive debate over the physiologically active and relevant 
form of the enzyme. Full-length wild-type A3G purifies as a combination of 18% 
monomers, 80% unresolved mixture of dimers to tetramers, and 2% high molecular 
weight aggregates. Deaminase activity has been observed directly in this complex 
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mixture and in mutant constructs specifically designed to be monomeric in solution. The 
monomer mutant of A3G retains both the specific activity and 30nt dead zone 
characteristics of the wild-type indicating that dimerization is not critical to A3G activity 
[41]. There is some contention that higher order oligomers are required for efficient 
deamination and viral restriction [46]. However, even the C-terminal domain alone 
demonstrates considerable deaminase activity allowing it to be used in isolation to 
determine kinetic parameters [28]. The most widely accepted active form is a dimer as 
there is the largest amount of direct and indirect data supporting this conformation. 
Atomic force microscopy measurements on ssDNA substrates in solution show a 
predominantly dimeric population attached to the target sites. A3G monomers were seen 
to readily bind ssDNA but rapidly dimerized, dimers were also seen to release a single 
monomer leaving the other monomer still bound to the DNA. While this technique is 
unable to distinguish which form was active in catalysis it indicates that the dimer is 
readily and even preferentially formed on substrate DNA [42]. AFM has also shown an 
interesting correlation between available binding area and multimeric state. On substrates 
shorter than the previously described, monomers have been seen binding in roughly equal 
proportions to dimers whereas dimers dominate on longer ssDNA segments indicating 
that monomer contact is sufficient to acquire the substrate but dimer is the preferred 
multimeric state [47].  
Dimer formation has the possibility of occurring in a number or orientations, 
CD1-CD1, CD2-CD2, and CD1-CD2 (Fig. 1.5). CD2-CD2 dimers have been postulated 
on the basis of SAXS data[45], but such dimers are not seen in catalytically active CD2 
only mutants used for NMR structural determination [28], [29]. A3G proteins that were 
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mutated in the N-terminal and C-terminal domains indicate that the N-terminal CD1-CD1 
dimers are the predominant form. Mutations made in the homologous regions of both the 
CD1 and CD2 domain contacts predicted by the A2 crystal structure only yielded a 
significant increase in monomer formation with the CD1 mutants. Residual dimer 
formation was observed in the CD1 mutant, attributable to minimal retained CD1-CD1 
affinity as well as CD1-CD2 and CD2-CD2 binding, but higher order oligomer formation 
was completely abolished [41].   
 
Fig. 1.5. Potential fl-A3G dimer interactions. Potential dimerization orientations for 
oligomerization of fl-A3G monomers into dimer, middle orientation (CD1-CD1 
interface) constitutes likely dimer form. Dimerization interface indicated by dashed line. 
 
1.11. Processivity  
A3G incorporated into budding HIV-1 virions in the producer cell has been 
shown to be necessary for active A3G deamination and restriction of HIV-1 in target cells 
[36], [37], [39], [48]. The amount of A3G incorporated into these virions correlates with 
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the extent of HIV-1 proviral DNA deamination in a linear fashion [49]. Incorporation of a 
small number of A3G active units into an HIV-1 virion can exhibit extensive deamination 
capacity. A3G active units incorporated into the virion show characteristic deamination 
profiles and multiple deaminations are visible upon incorporation of a single A3G active 
unit [49], [50]. As the active state of A3G (monomer, dimer or higher order oligomer) is 
unknown the term active unit refers to the oligomeric state able to cause deamination. 
Since it is clear that minimal amounts of A3G incorporation can lead to high levels of 
proviral DNA mutations the question of the mechanism of A3G action on extended 
sequences becomes relevant.  
A3G has demonstrated capacity to deaminate multiple target sequences in ssDNA 
substrates under single substrate binding conditions [32], [40], [41], [51], [52]. Sequential 
double deamination reactions are observed at a 6-7 fold excess over the predicted values 
of the rate of double deamination resulting from two independent A3G molecules. The 
range over which correlated single A3G molecule double deaminations are observed is 
from 3-100nt of intervening ssDNA [32]. This range is further confirmed by real-time 
AFM data showing single A3G units, in this case dimers, moving across ssDNA 
sequences of up to 69nt without dissociation [47]. In concert with the scanning motion 
exhibited by A3G productive binding results in extremely long dwell times on a single 
DNA target extending up to 10 minutes [51]. This extended dwell time coupled with 
scanning gives the opportunity for multiple coordinated deaminations.  
There is much discussion concerning the mechanism of A3G processivity with the 
two competing mechanisms being sliding/micro jumping and intersegmental transfer. 
Intersegmental transfer makes the case for the simultaneous binding of either two discreet 
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ssDNAs or the folding of a single target ssDNA in two positions. This simultaneous 
binding could be facilitated through the non-catalytic CD-1 or through the release of 
ssDNA by one subunit from a dimer [52]. Although for this to be the mechanism of 
proccessive deamination in the case of a single DNA strand the interactions between 
A3G and ssDNA would have to bring the tail end of the target into a position where it 
could be bound by the free CD-1 or the CD-2 domain of the un-bound monomer. Single 
molecule FRET (smFRET) experiments show that there is no significant contraction of 
the DNA when bound to A3G [51]. These experiments were done under conditions where 
A3G is predominantly monomeric so there is still a possibility that the dimer is capable 
of facilitating this contraction through an unknown mechanism.  The same smFRET 
experiments also indicate that A3G is capable of scanning ssDNA with and without a 
target motif. A3G exhibits the same degree of processivity on targets ranging from 3-100 
intervening bases giving weight to the scanning hypothesis [32]. The contribution of 
micro jumping in solution complicates the possibility for a single mechanism being 
responsible for coordinated deaminations. A3G has been shown to be able to catalyze 
coordinated deaminations on substrates with dsDNA segments annealed between target 
sites indicating that the A3G active unit must dissociate from the DNA and reattach to the 
same strand bypassing the double stranded region [40]. This micro jumping could be 
accomplished by either complete dissociation or by intersegmental transfer. In reality it is 
very likely that A3G translocation between adjacent sites is dictated by a combination of 
these two mechanisms depending on distance and environmental factors.  
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1.12. Summary 
Many structural factors contribute to A3G’s demonstrated capacity to restrict Vif-
deficient HIV-1 replication. High affinity for single stranded nucleotides leads to both the 
effective incorporation into nascent viral particles as well as efficient deamination of 
target ssDNAs. Active center loop 3 gives A3G target specificity leading to the 
introduction of premature stop codons. The N-terminal domain allows for 
multimerization leading to catalytically oriented active sites and increases ssDNA dwell 
time permitting multiple proccessive deaminations from a single A3G active unit. Current 
data in the field gives good insight into some mechanisms of A3G action, yet more 
information is still necessary for a complete picture. A high resolution structure of the N-
terminal non-catalytic domain would give insight into potential oligomerization 
interfaces. While a complex structure of the A3G/DNA interface would go a long way in 
determining the mechanism of target site recognition.  
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2.1 Synopsis 
 Full length APOBEC3G (fl-A3G) binds single stranded DNA (ssDNA) 
oligonucleotides and in a context specific manner deaminates a cytosine base to a 
deoxyuracil. In this chapter we report the catalytic parameters of the isolated C-terminal 
domain of APOBEC3G-2K3A (A3Gctd-2K3A), the minimal substrate for A3Gctd-
2K3A, the pH dependence of the catalytic rate, and the residue responsible for 
modulating the pH effects. fl-A3G, wild-type A3Gctd (wt-A3Gctd) and A3Gctd-2K3A 
all demonstrate a notable increase in the catalytic rate at low pH which allows for 
determination of Michaelis-Menten type kinetic parameters for the deamination of 
ssDNA under conditions suitable for NMR analysis. A3Gctd displays a reduced binding 
affinity for ssDNA while retaining a catalytic turnover rate similar to the holoenzyme. 
The C-terminal domain recognizes a minimal 5mer ssDNA substrate containing a 
centrally located 5’-CCC-3’ hotspot motif that is flanked by a single nucleotide on both 
ends. A single amino acid H216 was shown to be responsible for the pH dependence both 
A3Gctd-2K3A and fl-A3G.  
 
2.2 Introduction 
 Human APOBEC3G (A3G) is a member of a family of Zn2+-dependent 
polynucleotide cytosine deaminases. This family was named after APOBEC1 
(apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1) and also includes the 
antibody gene diversification enzyme AID (activation-induced cytidine deaminase) 
(reviewed in references [53]–[57]). A3G can restrict HIV-1 replication by packaging into 
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assembling viral particles for delivery to target cells, where it deaminates cytosine to 
uracil in newly transcribed viral DNA. These cDNA uracils base pair with adenine during 
plus-strand synthesis and result in G-to-A hypermutation and, in turn, inactivation of the 
viral genome. A3G has two Zn2+ binding domains that span residues 1 to 196 and 197 to 
384, but only the C-terminal domain is catalytically active [58]–[60]. The N-terminal 
domain interacts with HIV-1 Vif, RNA, and single-stranded DNA (ssDNA) (e.g., see 
references [59] and [61]–[63]). A3G predominantly deaminates the 3′ cytosine 
(underlined) in a 5′-CCC sequence, although the middle cytosine can also be deaminated 
in subsequent reactions following deamination of the 3′ cytosine [2], [3], [52], [64], [65]. 
In longer ssDNA substrates with multiple 5′-CCC sites, A3G deamination exhibits a 
3′→5′ spatial preference in vitro [61], [41], [66]. In the present study, we use the catalytic 
domain of A3G (A3Gctd) to determine kinetic parameters. Our results provide kinetic 
constants for two independent deaminations within a 5′-CCC sequence, which explain 
A3G's catalytic site preference for the 3′ cytosine. We identify a strong pH dependence of 
the reaction speed, which implies that a histidine residue is involved in substrate binding. 
In addition, we identify the shortest-length ssDNA substrate for A3Gctd to be a 
pentanucleotide. 
 
2.3 Results 
2.3.1 Time-resolved NMR analysis of DNA cytosine deamination catalyzed by 
A3Gctd 
 As shown in Fig. 2.1a, the progress of A3Gctd-catalyzed deamination of 5′-
ATTCCCAATT to 5′-ATTCCUAATT was monitored by using a series of 1H NMR 
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spectra. The rising product signal at 5.6 ppm is sufficiently resolved to allow quantitative 
analysis. By using appropriate enzyme and substrate concentrations, the speed of the 
reaction can be adjusted so that we can monitor the reaction course on a time scale of 
several hours. As shown in Fig. 2.1b, the speed of the catalytic reaction is constant for 
the first 25 data points. Thus, we can determine the initial speed of the reaction under the 
given conditions. This determination allows us to characterize the enzyme kinetics of 
A3Gctd by measurements at several different substrate concentrations. Our first attempt 
was performed at a physiological pH of 7.4. Although we used very high substrate 
concentrations of up to 10 mM, we were not able to saturate the enzyme. Instead, the 
initial speed of the reaction increased linearly with substrate concentration (Fig. 2.2a). 
We tested both wild-type A3Gctd and a soluble variant containing five substitutions, 
L234K, C243A, F310K, C321A, and C356A, called A3Gctd-2K3A [29] and found that 
both proteins exhibited the same linear dependence of reaction speed on substrate 
concentration. This finding suggested that either the reaction cannot be described by a 
Michaelis-Menten-type mechanism or saturation of the enzyme occurs at concentrations 
higher than 10 mM under the conditions used for these experiments. 
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Figure 2.1. Time-resolved NMR analysis of A3Gctd-catalyzed ssDNA cytidine 
deamination. (a) An enlarged region of a 1H spectrum of 5′-ATTCCCAATT-3′ is 
compared at several time points during a deamination reaction to illustrate the increase in 
the H5 proton signal of uridine due to formation of the product 5′-ATTCCUAATT-3′. 
The spectrum of a synthesized decanucleotide containing the product sequence is 
provided at the top, and that of the substrate is shown at the bottom. An 818 μM 
concentration of oligonucleotide was mixed with a 7.7 μM concentration of A3Gctd in 50 
mM phosphate buffer (pH 7.4) with 10% D2O at 25°C. After addition of enzyme and 
preparation of the spectrometer, a 1H spectrum was recorded every 220 s. (b) The H5 
proton signal of uridine at 5.60 ppm was integrated, calibrated, and plotted versus time. 
The straight line is a linear fit to the data. (c) Same as panel a, but the substrate is 5′-
ATTCCUAATT-3′, and the product is 5′-ATTCUUAATT-3′. A 237 μM concentration of 
oligonucleotide was incubated with 10 μM A3Gctd in 75 mM citrate buffer (pH 5.5) with 
10% D2O at 25°C. A 1H spectrum was recorded every 460 s. (d) The H5 proton signal of 
uridine at 5.69 ppm was integrated, calibrated, and plotted versus time. The straight line 
is a linear fit to the data.  
In order to find better conditions for kinetic analysis, we tested the influence of 
pH, salt concentration, and the presence of Mg2+, Ca2+, and Zn2+ in the buffer solution 
on the reaction speed of A3Gctd deamination. Only in the case of varied pH did we 
observe a strong influence on the reaction speed. At low substrate concentrations, the 
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reaction speed increased significantly with more acidic pH. As shown in Fig. 2.2b, wild-
type A3Gctd reaches a maximum enzymatic activity at pH 5.5, where the speed of 
reaction is ∼30 times higher than that at pH 7.5 (Fig. 2.2b, circles). Catalytic activity of 
the 2K3A variant peaked at pH 6.0 (Fig. 2.2b, stars). 
We therefore monitored deamination reactions of wild-type A3Gctd for several 
different substrate concentrations at pH 5.5. As shown in Fig. 2.2c, at pH 5.5, we were 
able to saturate the enzymes. The speed of enzymatic catalysis first increases with 
substrate concentration but then reaches a plateau (Fig. 2.2c). Accordingly, we fit the 
double-reciprocal data with a straight line to determine a wild-type Km of 0.57 ± 0.09 
mM and a kcat of 5.80 ± 2.20 deamination events per minute for the 5′-ATTCCCAATT-
to-5′-ATTCCUAATT reaction (Table 2.1). We also observed Michaelis-Menten-type 
behavior for A3Gctd-2K3A and obtained similar constants (Km = 1.4 ± 0.7 mM; kcat = 
4.6 ± 2.9 min−1). 
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Figure 2.2. Speed of A3Gctd-catalyzed deaminations. (a) Speed of A3Gctd-catalyzed 
5′-CCC-to-5′-CCU deamination at pH 7.4. The initial speed of the deamination was 
determined for different substrate concentrations for wild-type A3Gctd (circles) or the 
2K3A variant (stars). (b) pH dependence of the speed of A3Gctd-catalyzed deamination. 
5′-ATTCCCAATT-3′ oligonucleotides (300 μM) were incubated with wild-type A3Gctd 
(circles) or the 2K3A variant (stars), and the initial speed of the reaction at the indicated 
pH was determined. The ionic strength of the different buffers was adjusted to similar 
levels by addition of sodium chloride. (c) Substrate concentration dependence of A3Gctd-
catalyzed 5′-CCC-to-5′-CCU deamination at pH 5.5. Initial speed of the deamination at 
25°C was determined for several substrate concentrations using wild-type A3Gctd 
(circles) and the 2K3A variant (stars). For panels a to c, the data were collected from four 
independent enzyme preparations and calibrated to the same enzyme concentration of 
820 nM. (d) Substrate dependence of wild-type A3Gctd-catalyzed 5′-CCU-to-5′-CUU 
deamination at pH 5.5. Initial speed of catalysis was determined by using wild-type 
A3Gctd at a 2.4 μM concentration. To compare these data with those for the 5′-CCC-to-
5′-CCU reaction in panel c, the speed of the reaction was calibrated to an 820 nM enzyme 
concentration. For panels c and d, dashed lines show reaction curves generated by 
double-reciprocal (Lineweaver-Burk) analysis of the data. 
 The product of the initial deamination reaction, 5′-ATTCCUAATT, was further 
deaminated to 5′-ATTCUUAATT. This second product exhibited a distinct doublet NMR 
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signal at 5.69 ppm (Fig. 2.1c and d). We monitored wild-type A3Gctd's catalytic 
reactions with different 5′-ATTCCUAATT substrate concentrations to determine the 
initial speed of each reaction, which was plotted against the corresponding substrate 
concentration in Fig. 2.2d. The speed of this secondary deamination initially increases 
with increasing substrate concentrations but then plateaus. We determined Michaelis-
Menten constants by using the linear fit of double-reciprocal data to find that this reaction 
is significantly slower, with a kcat of less than 1 deamination event per minute (Table 
2.1). In addition, a higher Km was measured, which indicates that 5′-ATTCCUAATT 
binds A3Gctd with lower affinity than 5′-ATTCCCAATT. Moreover, the value of 
kcat/Km can be regarded as a substrate specificity constant [67]. This value was 
calculated to be 10 M−1 s−1 for 5′-ATTCCCAATT and 0.22 M−1 s−1 for 5′-
ATTCCUAATT. Therefore, A3Gctd exhibited a 45-fold greater preference for the 5′-
CCC substrate over the 5′-CCU substrate. It should be noted that we have previously 
shown that A3Gctd produces undetectable levels of 5′-CUC or 5′-UCC products from the 
5′-CCC substrate using an electrochemical deamination assay [68]. 
 
Table 2.1. Linear regression analysis of wild-type A3Gctd deaminase reactionsa 
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Figure 2.3. Speed of deamination catalysis as a function of substrate sequence. Initial 
speed was determined for the conversion of 600 μM substrate of the indicated sequence 
and A3Gctd-2K3A at pH 5.5. The enzyme concentration for all experiments was 820 nM, 
except for the 5′-CCCAA-3′ determination, for which 8.2 μM enzyme was used. The 
product concentration of 5′-CCCAA-3′ is calibrated to the 820 nM enzyme concentration. 
 
2.3.2 Determination of a minimum substrate for A3Gctd 
 To test whether H216 is responsible for the pH dependency of A3Gctd 
deamination, we mutated H216 to alanine (A3Gctd-2K3A-H216A) and to arginine 
(A3Gctd-2K3A-H216R) and measured reaction speeds at pH 7.3 and pH 6.0. A3Gctd-
2K3A-H216A was catalytically dead at pH 7.3 (data not shown), which is consistent with 
previous E. coli assay results [29]. In comparison, A3Gctd-2K3A-H216R showed a 
reaction speed similar to that of A3Gctd-2K3A at pH 7.3 (Fig. 2.4b). The difference was 
revealed at pH 6.0, as A3Gctd-2K3A's reaction speed was 8-fold higher than that at pH 
7.3, while A3Gctd-2K3A-H216R showed only a modest 1.4-fold increase in the reaction 
speed (Fig. 2.4b). 
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Figure 2.4. Role of H216 in A3Gctd's catalytic reaction. (a) Locations of 10 histidine 
residues in the three-dimensional structure of A3Gctd (Protein Data Bank [PDB] 
accession number 3IR2). A Zn atom (pink) is coordinated by H257, C288, and C291 
(blue). H216 is shown in green, whereas all other histidines are gray. Two loops spanning 
residues 207 to 217 and 313 to 320 are shown in pink. (b) pH dependence of the speed of 
A3Gctd-2K3A-catalyzed deamination. 5′-ATTCCCAATT-3′ oligonucleotides (150 μM 
concentration) were mixed with a 1.5 μM concentration of the A3Gctd-2K3A (black 
diamonds) or A3Gctd-2K3A-H216R mutant (red circles) in sodium-phosphate buffer at 
pH 7.3 or pH 6.0, and the initial speed of the reaction was determined. Three independent 
experiments were conducted for each pH, and error bars show standard errors. 
 
2.3.3 pH dependency of full-length A3G deamination 
 We next used a FRET-based deamination assay to ask whether wild-type full-
length A3G deamination is similarly modulated by pH. Figure 2.5 shows that A3G has 4-
fold-higher deamination activity at pH 5.5 than at pH 7.4 (values were compared at a 33.7 
nM protein concentration). Since we observed increased deamination activity at lower 
pH, we generated H216A (A3G-H216A) and H216R (A3G-H216R) variants of full-
length A3G in order to find whether H216 is responsible for the pH dependence of 
deamination activity. Figure 2.5 shows that A3G-H216A was catalytically dead at pH 7.4 
as well as at pH 5.5, but A3G-H216R had deamination activity similar to that of wild-
type A3G at pH 7.4. Interestingly, A3G-H216R showed only 1.5-fold-higher deamination 
activity at pH 5.5 than at pH 7.4 (values were compared at a 33.7 nM protein 
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concentration) (Fig. 2.5), further indicating that protonation of H216 is a key part of the 
mechanism by which A3G shows increased deamination activity at pH 5.5. 
 
Figure 2.5. pH dependence of the deamination activities of A3G, A3G-H216A, and 
A3G-H216R. (a) Purities of A3G, A3G-H216A, and A3G-H216R, as shown by SDS-
PAGE and Coomassie blue R250 staining. These purified proteins were used for 
deaminase activity assays shown in panel b. BSA, bovine serum albumin. (b) pH 
dependence of deaminase activities of A3G at pH 5.5 (red diamonds), A3G-H216A at pH 
5.5 (red squares), A3G-H216R at pH 5.5 (red triangles), A3G at pH 7.4 (white 
diamonds), A3G-H216A at pH 7.4 (white squares), and A3G-H216R at pH 7.4 (white 
triangles). Deaminase activities are shown by using fluorescence intensity emitted by 
products in relative fluorescence units (RFU). 
 
2.3.4 Impact of H216 mutations on HIV-1 restriction activity 
 Since H216 is important for A3G's deaminase activity, A3G-H216R and A3G-
H216A were tested for their capability to restrict HIV infection. A3G-H216A showed 
almost no restriction capability, but A3G-H216R maintained restriction of HIV infection 
(Fig. 2.6). The restriction activity of A3G-H216R was slightly weaker than that of wild-
type A3G, consistent with biochemical data presented above and prior studies 
demonstrating the importance of DNA deaminase activity for full levels of HIV-1 
restriction [69], [5], [70]. 
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Figure 2.6. HIV-1 restriction activities of A3G-H216A and A3G-H216R. HIV-1 ΔVif 
infectivity was determined by measuring the ratio of GFP-expressing target 293T cells by 
flow cytometry. Each data point represents the average of three independent reactions. 
The standard deviations are shown as error bars. The expression of A3G-mycHis and 
mutant proteins in producer 293T cells was detected by Western blotting using an A3G 
monoclonal antibody (catalog number 7105; ImmunoDiagnostics). Gag (p55) was 
detected by using a p24 monoclonal antibody, and β-tubulin is shown as a loading 
control. 
 
2.4 Discussion 
 A3G predominantly deaminates 3′ cytosine in a 5′-CCC sequence ([2], [3], [52], 
[64], [65]). The middle cytosine can be deaminated, but its deamination speed is much 
lower than that of the primary 3′ cytosine. Previous studies failed to distinguish A3G's 
preference for the primary 3′ cytosine. We used time-resolved NMR, which was 
originally proposed by Furukawa and coworkers [64], to determine kinetic parameters for 
A3Gctd-catalyzed deamination. The reaction speed was maximal at pH 5.5, and it 
followed Michaelis-Menten-type kinetics. This pH dependency may imply involvement 
of histidine residues for substrate binding and/or the catalytic reaction, since the pKa 
value of the conjugated acid of imidazole is around pH 6.0. A3Gctd contains 10 histidine 
residues, including a Zn2+-coordinating histidine, H257. Protonation of a Zn2+-
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coordinating histidine is likely to destabilize the protein structure, and this is probably the 
reason for the decline of catalytic activity observed at pH 4.5. E. coli cytidine deaminase, 
which has a Zn2+-coordinating histidine, did not show a maximum reaction speed at pH 
5.5 to 6.0 [71]. Therefore, H257 is not likely the cause of the observed pH dependency of 
A3Gctd deamination. Among the remaining histidines, alanine mutants of H216 and 
H345 have shown reductions in mutation frequency of 30-fold and 10-fold, respectively, 
whereas substitution of the others maintained >25% of wild-type catalytic activity [29], 
[72]. H216 was one of the five most perturbed residues upon titration of a 21-mer single-
stranded DNA containing a 5′-CCC hot spot, identified by monitoring main-chain 1H-
15N chemical shifts [73]. Figure 2.4a shows positions of all histidine residues in a three-
dimensional structure of A3Gctd. Loops spanning residues 207 to 217 and 313 to 320 are 
also shown in color, since they have been suggested to play important roles in DNA 
binding [61], [66], [29], [30], [73], [74]. H216 is located in the loop at residues 207 to 
217, and it is spatially close to the catalytic site (Fig. 4a). Indeed, amino acid 
substitutions of H216 modulated catalytic activity of A3Gctd-2K3A, as A3Gctd-2K3A-
H216A was catalytically dead, whereas A3Gctd-2K3A-H216R, as well as A3Gctd-
2K3A, was active at pH 7.3, and it showed only a modest increase in catalytic speed at 
pH 6.0 (Fig. 4b). Therefore, it is plausible that H216 interacts with substrate DNA using a 
mechanism which is enhanced by protonation of its imidazole ring. Importantly, wild-
type full-length A3G also showed a significant increase in deamination activity at pH 5.5 
(Fig. 5), indicating that the results obtained with A3Gctd reflect the DNA binding and 
deamination mechanism of the full-length enzyme. It should also be noted that full-length 
A3G binds 10-mer ssDNA as strongly as 69-mer ssDNA, with apparent Kd (dissociation 
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constant) values of 50 nM and 52 nM, respectively [61], suggesting that shorter 
substrates make all essential contacts required for binding and catalysis. Furthermore, our 
data indicate that the observed pH dependency is independent of substrate length, as 
shorter substrates (decamer in NMR experiments) and longer substrates (24-mers in 
FRET-based experiments) behaved similarly. There were small but significant decreases 
in viral restriction with A3G-H216R compared to wild-type A3G, although A3G-
H216R's deamination activity was very similar to wild-type A3G activity at pH 7.4 (Fig. 
2.5 and 2.6). These data imply that H216 may be protonated to increase A3G's catalytic 
activity inside the viral capsid during reverse transcription. 
The Km value for 5′-CCC-to-5′-CCU deamination by A3Gctd is on the same 
order of magnitude as mononucleoside deamination by E. coli cytidine deaminase (0.12 
mM), whereas A3Gctd's kcat value is much lower than the value of 299 s−1 determined 
for E. coli cytidine deaminase [75]. A3Gctd's kcat value is similar to that determined for 
human RNA-editing adenosine deaminase 2 (ADAR2) (0.88 min−1) [76]. A common 
feature between ADAR2 and A3G is that both require binding to polynucleotide 
substrates prior to deamination, as ADAR2's substrate is duplex RNA [77], [78] and 
A3G's substrate is single-stranded DNA, whereas E. coli cytidine deaminase deaminates 
the mononucleoside cytidine. Therefore, A3Gctd and ADAR2 may take additional time 
to position their substrates before catalysis can occur, which may cause their speed of 
deamination to be lower than that of E. coli cytidine deaminase. The kcat value of 
A3Gctd is on the same order of magnitude as the reported kcat value of wild-type full-
length A3G (9.78 ± 2.4 min−1) [52], while the Km value of wild-type A3G was reported 
to be 0.82 ± 0.06 nM [52], which is 105 times lower than that of A3Gctd. The 
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nonspecific ssDNA binding of wild-type A3G, with a dissociation constant of 52 to 238 
nM, is much stronger than that of A3Gctd, which has a dissociation constant of 130 to 
400 μM [29], [52], [61], [62], [64], [66], [79]. Thus, the large difference in Km values 
may be partly due to the stronger binding capability of the N-terminal domain of A3G, 
which was not present in our NMR studies because full-length A3G aggregates at higher 
protein concentrations. It should be noted that the above-mentioned Km value was 
determined by using an 80-mer oligonucleotide substrate containing one 5′-CCC hot spot 
([52]; see also references [61] and [66]), suggesting that longer substrates are more 
efficiently deaminated than shorter substrates, since deamination predominantly occurs 
when A3G approaches a 5′-CCC target with a 3′→5′ orientation. Therefore, it is plausible 
that 3′→5′ sliding enhances the likelihood of binding in a catalytically active orientation 
of substrate DNA, which could explain the lower Km value determined by using a longer 
ssDNA substrate [52]. 
Although RNA- and ssDNA-dependent oligomerization of A3G has been 
observed, atomic force microscopy studies showed that A3G was able to bind and slide 
over ssDNA as a monomer [61], [66], [69], [80]–[84]. In addition, a double mutant 
(F126A/W127A) that was predominantly monomeric in solution bound ssDNA and 
catalyzed deamination with 3′→5′ directionality similarly to wild-type A3G [41]. 
Therefore, monomeric A3Gctd is a useful model for studying the kinetic parameters of 
the full-length enzyme. 
The minimum substrate length for A3Gctd was found to be a pentamer containing 
a 5′-CCC hot spot flanked on both sides by one nucleotide, suggesting that key 
interactions for substrate specificity may involve these five nucleotides. This result is 
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consistent with substrate specificity studies using nucleoside analogues, which revealed 
that A3G was sensitive to nucleotides at positions −3 to +1 of the primary target cytosine 
[65]. The present study provides fundamental knowledge of A3G-catalyzed cytosine 
deamination and may aid in the design of ssDNA for high-resolution structure 
determination of an A3G-substrate complex. 
 
2.5 Methods summary  
2.5.1 Purification of A3Gctd 
The APOBEC3G C-terminal domain (A3Gctd), comprising amino acids 191 to 
384, was expressed and purified as previously described ([25]). Briefly, the glutathione 
S-transferase (GST)-fused A3Gctd was expressed in Escherichia coli BL21(DE3) cells 
overnight at 17°C. After harvesting, the cells were resuspended in 50 mM sodium 
phosphate buffer (pH 7.4) and lysed by sonication. After ultracentrifugation at 25,000 × g 
for 10 min, the supernatant was added to glutathione (GSH)-Sepharose, which was 
subsequently washed. For kinetic analysis, the GST fusion protein was eluted from the 
Sepharose matrix with 100 mM GSH in phosphate buffer. By using filtration at 4,000 × 
g, the buffer was changed to a solution containing 50 mM phosphate (pH 7.4), 50 mM 
NaCl, 50 μM ZnCl2, and 10% glycerol, and the protein was concentrated and frozen for 
storage. For pH analysis and measurements at pH 5.5, the buffer was composed of 75 
mM sodium phosphate and 75 mM citrate, and the pH was adjusted accordingly. The 
ionic strength of different buffers was adjusted by using sodium chloride. 
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2.5.2 Kinetic analysis of A3Gctd's deaminase activity 
Kinetic measurements were conducted in the same buffer at a glycerol 
concentration of 0.6% and with 10% deuterium oxide. All nuclear magnetic resonance 
(NMR) data were acquired on a 700-MHz Bruker NMR spectrometer equipped with a 
1.7-mm cryoprobe. A series of 1H spectra of the oligonucleotide substrates including 5′-
ATTCCCAATT-3′, 5′-ATTCCUCAATT-3′, 5′-ATTCUUAATT-3′, 5′-ATTCCCA-3′, 5′-
TTCCCA-3′, 5′-TCCCA-3′, 5′-CCCAA-3′, and 5′-TTCCC-3′ at concentrations ranging 
from 100 μM to 10 mM was recorded. The spectra were baseline corrected, and the H5 
proton signals of the 3′ and middle uracils from the 5′-CCU and 5′-CUU products, 
respectively, were integrated; these appeared at 5.60 ppm and 5.69 ppm, respectively. 
Two groups of signals were used as an internal standard in order to determine the product 
concentration during the reaction, including oligonucleotide signals at 8.18 to 7.97 ppm 
and a doublet of doublets at 2.57 to 2.39 ppm originating from citrate buffer. The product 
signal area was converted to product concentration and plotted versus time of reaction. 
To determine the initial speed, this plot was fitted with linear regression, and the slope of 
the initial linear part was recorded as initial speed. Enzyme concentrations were 
determined by SDS-acrylamide gel electrophoresis. A dilution series by a factor of 5 of 
the protein of interest was prepared, and usually, three samples were loaded onto an 18% 
gel. To calibrate the measurement, commercial carbonic anhydrase (CA) was weighted to 
10 mg/ml. A dilution series by a factor of 1.5 of the 1-mg/ml CA solution was loaded 
next to the protein of interest. After electrophoresis and staining, the gel was 
photographed, and the image was analyzed by using ImageJ [85]. 
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2.5.3 Purification of full-length A3G 
Full-length A3G-mycHis, A3G H216A-mycHis, and A3G H216R-mycHis 
proteins were purified from transiently transfected 293T cells as described previously 
[26], [69]. Briefly, 293T cells were maintained in Dulbecco's modified Eagle's medium 
(DMEM) (Invitrogen) with 10% fetal bovine serum (FBS) (Gibco), 50 units/ml 
penicillin, and 50 μg/ml streptomycin (Invitrogen) at 37°C in 5% CO2. Forty-eight hours 
after transfection with TransIT-LTI (Mirus Bio), cells were harvested and lysed in a 
solution containing 25 mM HEPES (pH 7.4), 150 mM NaCl, 1 mM MgCl2, 1 mM 
ZnCl2, 1 mM EDTA, 0.5% Triton X-100, and 10% glycerol. The soluble cell lysates 
were harvested by centrifugation (14,000 rpm for 10 min), and A3G-mycHis proteins 
were purified by affinity chromatography with Ni-nitrilotriacetic acid (NTA) agarose 
(Qiagen). The purified proteins were subjected to SDS-PAGE/Coomassie blue R250 
staining for purity and concentration determination. 
 
2.5.4 FRET-based deamination assay 
Fluorescence resonance energy transfer (FRET)-based deamination assays were 
performed as described previously [26], [69], [86], [87]. Purified A3G-mycHis and 
mutant proteins were incubated with a dually labeled single-stranded DNA (5′–6-
carboxyfluorescein [FAM]–AAATATCCCAAAGAGAGAATGTGA–6-
carboxytetramethylrhodamine [TAMRA]–3′) (Biosearch Technologies, Inc.) and E. coli 
uracil-DNA glycosylase (NEB) in a 384-well black plate (Nunc) at 37°C for 2 h. The 
products with abasic sites were cleaved by adding 3 μl of 4 N NaOH. The pH of the 
reaction solution was regulated with 3 μl of 4 N HCl and 37 μl of 2 M Tris-Cl (pH.9), and 
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the fluorescence was read in a Synergy Mx monochromator-based multimode microplate 
reader (BioTek). 
Single-cycle HIV-1 infectivity assay.Single-cycle HIV-1 infectivity assays were 
performed as described previously [88]. 293T cells were plated into a 6-well plate and 
transfected with 0.22 μg pCS-CG, 0.14 μg pRK5/Pack1 (Gag-Pol), 0.07 μg pRK5/Rev, 
and 0.07 μg pMDG (vesicular stomatitis virus G protein) along with 4.4, 5.5, 7.3, 11, or 
22 ng of pcDNA3.1-A3G-mycHis plasmid or mutant A3G plasmids by using TransIT-
LTI (Mirus Bio). After 48 h of incubation, virus-containing supernatants were harvested 
to infect target 293T cells. The transduced target 293T cells were harvested after an 
additional 24-h incubation and subjected to flow cytometry (BD FACSCanto II) to 
measure the ratio of green fluorescent protein (GFP)-expressing cells. 
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3.1 Synopsis 
 APOBEC3G is capable of finding and deaminating cytidines in ssDNA located in 
specific motifs while excluding oligonucleotides containing a single RNA base at the 
target position. In this chapter we examine the structural interactions involved in catalytic 
substrate binding, discrimination between target motifs, and the mechanism for exclusion 
of non-target nucleotides. A3Gctd binds ssDNA with an extended binding interface that 
encompasses a large portion of the catalytic face of the protein. A3Gctd undergoes 
significant conformational flexing during catalytic binding and deamination resulting in 
the perturbation of multiple residues located in the core of the protein. A3Gctd binds 
ssDNA non-specifically through a small subset of the binding residues and selectively 
engages substrates containing the target motif through a more extensive set of adjacent 
residues. We show that A3Gctd fails to engage the more extensive set of residues on 
substrates containing target nucleotides that preferentially exhibit the C3’-endo 
conformation typical of RNA. We also identify a novel substrate for A3G containing a 
2’-F-ANA cytidine at the target position, which adopts the C2’-endo conformation seen 
in the canonical substrate ssDNA.  
 
3.2 Introduction 
 APOBEC3G has an important role in human defense against retroviral pathogens, 
including HIV-1. Its single-stranded DNA cytosine deaminase activity, located in its C-
terminal domain (A3Gctd), can mutate viral cDNA. Targeted deamination of the viral 
genome effects viral genome stability manifesting in reduced integration and non-
functional gene products [3], [48], [53]. This deamination occurs in a context dependent 
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manner, selectively targeting a minimal di-cytidine motif [16], [17], [64], [65], [68], [74], 
[89], [90]. We previously showed that the C-terminal domain of APOBEC3G 
preferentially deaminates the 3’ cytidine in the hotspot 5’-CCC motif with a 45-fold 
greater preference than the di-cytidine substrate motif 5’-CCU [17]. In the same study we 
determined that A3Gctd demonstrates a considerable increase in the catalytic rate at 
reduced pH with a maximal increase at pH 6.0. We identified the histidine at position 216 
to be responsible for the pH sensitivity as arginine and alanine substitutions in this 
position resulted in a loss of pH sensitivity or a complete loss of deamination activity, 
respectively. H216 is located in a loop adjacent to the active site, but does not interact 
with the active site residues. Since H216 does not directly participate in deamination, we 
postulated that it must be involved in substrate binding and functions to increase A3Gctd 
affinity for substrate oligomers.  
Several APOBEC3 proteins have had their structures determined [18], [20], [22], 
[23], [25], yet to date no structures of an APOBEC protein has been solved in complex 
with DNA. NMR studies have been pursued with APOBEC3A [20] and APOBEC3G 
[29], both studies suffered from low substrate affinities (~55µM for A3A, ~450µM for 
A3Gctd) resulting in small chemical shift perturbations. Structural interactions of ssDNA 
with APOBEC3A indicate an extended binding interface involving residues in loop 7, 
between β4 and α4, and loop 3, between β2 and α2, along with residues immediately 
surrounding the catalytic site [20]. Molecular dynamics simulations of the related protein 
AID with substrate DNA display a similar binding interface[91]. 
A3G interacts extensively with both endogenous and viral RNAs through its N-
terminal domain. This interaction is involved in subcellular localization to mRNA 
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processing bodies and incorporation into viral particles [59], [92], [93]. A3G strongly 
binds RNA, which contains a plethora of di-cytidine motifs, but displays no catalytic 
activity on RNA nucleotides [89]. The lack of activity on RNA cytidines must be the 
result of a yet to be identified gating interaction between A3Gctd and RNA. Kohli and 
coworkers proposed a mechanism for AID’s lack of deamination of RNA substrates 
involving the pucker of the ribose sugar [94].  DNA predominantly assumes the C2’-endo 
conformation, while RNA assumes the C3’-endo conformation. These two conformations 
position the nucleotide base in different orientations with respect to the sugar. AID 
displayed activity on substrates containing 2’-F-ANA and ANA substrates, both of which 
assume the canonical DNA C2’-endo conformations [94].  
Given the lack of significant structural data on the binding of APOBEC3G to 
substrate DNA, an unknown mechanism of RNA exclusion, and APOBEC3G’s important 
role in HIV-1 restriction; we have undertaken this study to determine the A3Gctd 
substrate interface with DNA, RNA, and conformational mimics. Taking advantage of 
the increased substrate affinity of A3Gctd at low pH we have identified the relevant 
interactions of A3Gctd with various oligonucleotides.  
 
3.3 Results 
3.3.1 pH 6.0 assignment of A3Gctd-2K3A and A3Gctd-2K3A E259A mutant 
 As previously reported [17], A3Gctd-2K3A binds ssDNA with a higher affinity at 
low pH with a maximal increase in catalytic rate at pH 6.0. In order to assess the effects 
of reduced pH on the ssDNA binding of A3Gctd we first had to assign the NMR 
chemical shifts at pH 6.0. Initial pH titration data for A3Gctd-2K3A indicated a 
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substantial number of shifts in NMR peak positions that correlated exclusively to solvent 
exposed residues. Since the surface residues exhibited fast exchange dynamics, we were 
able to follow peak shifts through a range of titration points from the previously reported 
[25] chemical shifts to assign the pH 6.0 spectrum (Fig. 3.1).  
 
Fig. 3.1. pH titration of A3Gctd-2K3A. 1H-15N HSQC spectra overlay of A3Gctd-
2K3A at pH 7.0 (red), pH 6.6 (orange), pH 6.3 (cyan), pH 6.0 (blue).  
 
To determine specific binding differences between potential substrates, a single 
alanine point mutation was introduced at the catalytic glutamate (E259A) to produce a 
catalytically inactive mutant A3Gctd-2K3A E259A protein. The resulting A3Gctd-2K3A 
E259A spectrum displayed multiple chemical shift perturbations compared to the 
A3Gctd-2K3A reference, requiring de novo assignment of A3Gctd-2K3A E259A. Due to 
increased protein stability, the initial assignment was done at pH 7.3 and the assignments 
were transferred to the pH 6.0 spectrum in the same manner as A3Gctd-2K3A. We were 
able to assign 76% of non-proline main chain residues at pH 6.0, representative of a 
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majority of the surface exposed binding area. A small number of residues were absent at 
pH 6.0 that were assigned at pH 7.3, indicating that dynamics of those residues may 
change at low pH.  
 
Fig. 3.2.a. Assignment of A3Gctd-2K3A E259A at pH 6.0. 1H-15N HSQC spectrum of 
A3Gctd-2K3A E259A. Peak assignments determined using TROSY versions of HNCA, 
HN(CO)CA, HNCACB, HN(CO)CACB, HNCO, HN(CA)CO triple resonance 
experiments. (Insets in Fig. 3.2.b below) 
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Fig. 3.2.b. Assignment of A3Gctd-2K3A E259A at pH 6.0. Inset locations indicated 
with colored boxes (Fig. 3.2.a) corresponding to expanded inset spectrum borders.  
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3.3.2 Single-stranded DNA binding of A3Gctd-2K3A undergoing active catalysis 
 A3Gctd-2K3A rapidly deaminates substrates that include the hotspot target 
sequence 5’-CCC motif. To capture A3Gctd-2K3A during active catalysis, we acquired 
spectra with a 20-fold excess of substrate ssDNA 5’-AATCCCAAA at pH 6.0 in a time 
window that ensured catalysis was actively proceeding. We confirmed that we were 
acquiring data during the appropriate time period by monitoring the 1D 1H substrate 
spectrum at the end of the HSQC acquisition and verifying that non-deaminated substrate 
is still present (Fig. 3.3). Following the acquisition period the 3’ cytidine was completely 
deaminated and approximately half of the middle cytidine had been deaminated resulting 
in a spectrum that contained a mixture of 5’-AATCCCAAA and 5’-AATCCUAAA 
binding.   
 A3Gctd 2K3A shows substantial perturbation upon ssDNA binding. The bound 
spectrum displayed both chemical shift perturbations and intensity changes. Significantly 
perturbed residues were W211NE, R215, T218, R239, L242, L253, E254, A258, D274, 
D276, R278, W285NE, E294, I314, G319, D365, L375, and H376. Significant intensity 
reductions were seen for residues S196, E209, W211NE, A243, N244, A246, F252, 
G255, R256, H257, L260, F262, L263, W269NE, D274, S284, W285, C288, A292, 
M295, F298, A312, I314, D316, L328, I337, M338, F350, and L375.  
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Fig. 3.3. A3Gctd-2K3A perturbations upon AATCCCAAA binding. (a) 1H-15N 
HSQC spectrum of 4mM 5’-AATCCCAAA : 0.2mM A3Gctd-2K3A pH 6.0 (red) 
overlaid onto A3Gctd-2K3A (black) at pH 6.0 (potential target cytidines underlined). 
Spectra were acquired with 8 scans and 64 real points in the indirect dimension. 
Significantly shifted peaks labeled. (b) Quantification of peak intensity changes (gray 
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bars, left axis) and chemical shifts (red bars, right axis). Significant changes in either 
peak intensity or chemical shift are indicated by colored residue names, cyan indicates 
core residue, red indicates surface residue. Asterisks indicated residues that have two 
distinct peaks at pH 6.0. (c) 1D 1H spectra of substrate and product oligomers (bottom 
three spectra) and 1D 1H spectra of 20:1 AATCCCAAA:A3Gctd-2K3A pH 6.0 at mid-
HSQC and post-HSQC time points.  
 
3.3.3 Substrate oligomer binding to A3Gctd-2K3A E259A 
 Not all target 5’-CC (deamination target cytidine underlined) sites are deaminated 
with equal efficiency. In order to determine binding changes that are responsible for these 
disparities we titrated A3Gctd-2K3A E259A with different substrate and non-substrate 
oligomers. We first bound A3Gctd-2K3A E259A with the 5’-AATCCCAAA (5’-CCC) 
substrate containing a centrally located 5’-CCC hotspot motif (Fig. 3.4). A3Gctd-2K3A 
E259A showed substantial perturbation upon saturation with the substrate. Perturbations 
were localized to the predicted binding surface of the protein with additional 
perturbations to the neighboring loops and helices along with core beta sheets of the 
protein indicative of structural rearrangement. Binding perturbed four primary regions of 
the protein. Binding region 1 (BR1) spans residues T201-L220, with significant 
perturbation of residues F202, F206, E209, W211NE, R215, and L220. BR1 includes 
residues in helix 1 spanning 198-208. Binding region 2 (BR2) spans residues R238-K270, 
with significant perturbation of residues R238, R239, L242, N244, Q245, and A246, in 
the non-continuous β2 sheet. Residues G251, E254, R256, H257 (Zn2+ coordinating His 
residue), and A258 in the loop leading to the catalytic site show extensive perturbation 
upon DNA binding. F262, L263, V265, and W269, all located in the α2 helix following 
the catalytic residue with their side chains directed into the core, display slow exchange 
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dynamics upon binding indicative of core structure rearrangement. W285 constitutes the 
bottom of the catalytic pocket [29], displays slow exchange dynamics and exhibits the 
single greatest change in chemical shift upon DNA binding. Binding region 3 (BR3) 
spans non-consecutive residues W285, T311-E330, and I335-T339 containing the 
previously identified substrate recognition loop T311-G319 [16], [74] and form the left 
side of the binding surface. Residues A312, R313, and Y315 display substantial 
perturbation and slow exchange dynamics. Residues in the α4 helix including E323, 
G324, L325, R326, T327, L328, and E330 are undergoing intermediate exchange 
dynamics with reductions in intensity greater than 60 percent. Residues F358, G363, 
L364, and R374 show reduced intensity and D365 displays extensive perturbation. D365 
has been previously implicated in dimerization of C-terminal domains [72]. 
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Fig. 3.4. A3Gctd-2K3A E259A binding to hotspot 5’-CCC motif. (a) 1H-15N HSQC 
spectrum of 1mM 5’-AATCCCAAA : 0.2mM A3Gctd-2K3A E259A (red) overlaid onto 
0.2mM A3Gctd-2K3A E259A (black) at pH 6.0 (target cytidine underlined). Spectra 
were acquired with 128 scans and 100 real points in the indirect dimension. Significantly 
shifted peaks labeled. (b) Quantification of peak intensity changes (gray bars, left axis) 
and chemical shifts (red bars, right axis). Significant changes in either peak intensity or 
chemical shift are indicated by colored residue names, cyan indicates core residue, red 
indicates surface residue.  
 
 We then bound A3Gctd-2K3A E259A with 5’-AATCCUAAA to determine the 
binding profile of a substrate containing a di-cytidine motif representative of the minimal 
A3G target (Fig 3.5). Utilizing the 5’-CCU target site also helps to elucidate the factors 
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that limit sequential deamination of the 5’-CCC target that has been observed by several 
groups [17], [64], [69], [89]. The 5’-AATCCUAAA (5’-CCU) substrate oligomer 
displays a similar binding profile to the 5’-AATCCCAAA substrate and engages all of 
the same binding regions. However, A3Gctd-2K3A E259A shows no slow exchange 
dynamics with the 5’-CCU substrate as was seen in the 5’-CCC substrate indicative of a 
difference in the binding kinetics between the two substrates. BR1 overall shows a 
limited changes in peak intensity with W211NE and R215 showing significant changes in 
intensity. BR2 displays significant intensity changes at residues R238, R239, G240, 
F241, N244, Q245, A246, G251, E254, G255, R256, H257, A258, F262, L263, D264, 
V265, and W269NE. BR3 displays significant intensity changes at residues W285NE, 
S286, A312, R313, Y315, D316, G319, E323, G324, L325, R326, T327, L328, E330, 
A333, M338, and T339. C-terminal residues D365, H367, and R376 also display 
significant intensity changes.  
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Fig. 3.5.  A3Gctd-2K3A E259A binding to minimal di-cytidine target motif. (a) 1H-
15N HSQC spectrum of 1mM 5’-AATCCUAAA : 0.2mM A3Gctd-2K3A E259A (red) 
overlaid onto 0.2mM A3Gctd-2K3A E259A (black) at pH 6.0 (target cytidine 
underlined). Spectra were acquired with 128 scans and 100 real points in the indirect 
dimension. Significantly shifted peaks labeled. (b) Quantification of peak intensity 
changes (gray bars, left axis) and chemical shifts (red bars, right axis). Significant 
changes in either peak intensity or chemical shift are indicated by colored residue names, 
cyan indicates core residue, red indicates surface residue. 
 
3.3.4 Non-substrate oligomer binding to A3Gctd-2K3A E259A 
 In order to determine non-specific DNA binding effects on A3Gctd-2K3A E259A 
we then bound the protein to a non-substrate oligomer 5’-AATCUUAAA (5’-CUU), 
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which lacks a 5’-CC target site (Fig. 3.6). The overall binding profile of the 5’-CUU 
oligomer shows no chemical shift perturbation upon binding and limited localized 
changes in peak intensities. Interaction with BR1 is almost completely abrogated with the 
exception of W211NE and R215. BR2 displays non-consecutive changes in peak 
intensity limited to N244, A246, E254, R256, H257, and L263. BR3 is almost completely 
unperturbed with the exception of D316. Addition of five-fold excess 5’-AAAAAAAAA 
oligomer to A3Gctd-2K3A E259A (data not shown) displayed the same reductions in 
intensity confirming that 5’-CUU behaves the same as ssDNA lacking cytidine.  
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Fig. 3.6. A3Gctd-2K3A E259A binding to non-substrate oligomer. (a) 1H-15N HSQC 
spectrum of 1mM 5’-AATCUUAAA : 0.2mM A3Gctd-2K3A E259A (red) overlaid onto 
0.2mM A3Gctd-2K3A E259A (black) at pH 6.0. Spectra were acquired with 128 scans 
and 100 real points in the indirect dimension. Significantly shifted peaks labeled. (b) 
Quantification of peak intensity changes (gray bars, left axis) and chemical shifts (red 
bars, right axis). Significant changes in either peak intensity or chemical shift are 
indicated by colored residue names, cyan indicates core residue, red indicates surface 
residue. 
 
3.3.5 Ribose containing oligomer binding to A3Gctd-2K3A E259A 
 The introduction of a single RNA base at the 3’ position of the 5’-CCC hotspot 
motif has been shown to eliminate A3G catalytic activity on the ribose modified substrate 
[17], [65], [89]. In order to test the effects of this ribose substitution on the ssDNA 
binding of A3Gctd-2K3A E259A, we added excess 5’-ATTCCrCAATT (5’-CCrC) to the 
enzyme and observed the 15N-HSQC spectrum of the protein (Fig. 3.7). BR1 interaction 
is limited to W211NE and R215. BR2 shows significant intensity changes at residues 
R238, N244, A246, E254, R256, H257, F262, and L263. Interestingly, residue Q275 
which is outside of the established binding regions also exhibits a significant change in 
intensity. BR3 interaction is limited to W285NE, D316, G319, G324, and L325. Residues 
G355, D365, and R367 also show intensity changes consistent with those seen in other 
binding regions.  
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Fig. 3.7. A3Gctd-2K3A E259A binding to ribose target cytidine. (a) 1H-15N HSQC 
spectrum of 1mM 5’-AATCCrCAAA : 0.2mM A3Gctd-2K3A E259A (red) overlaid onto 
0.2mM A3Gctd-2K3A E259A (black) at pH 6.0. Spectra were acquired with 128 scans 
and 100 real points in the indirect dimension. Significantly shifted peaks labeled. (b) 
Quantification of peak intensity changes (gray bars, left axis) and chemical shifts (red 
bars, right axis). Significant changes in either peak intensity or chemical shift are 
indicated by colored residue names, cyan indicates core residue, red indicates surface 
residue. Asterisks indicate increases in peak intensity.  
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3.3.6 2’-F-RNA and 2’-F-ANA containing oligonucleotide binding to A3Gctd-2K3A 
E259A 
 Two potential mechanisms could be responsible for the exclusion of ribose bases 
from catalysis by A3G, the presence of the hydroxyl moiety at the C2’ position of the 
target sugar or the base conformation of the target sugar with ribose bases preferring the 
C3’-endo conformation and deoxyribose bases preferring the C2’-endo conformation 
[90]. To discriminate between these two possible mechanisms we assayed two fluorinated 
cytidine substrates, the first containing a fluorine substituted for the C2’ hydroxyl of the 
ribose (2’-deoxy-2’-fluororibonucleic acid, 2’-F-RNA) and the second containing an 
arabinose sugar with the C2’ hydroxyl substituted for fluorine (2’-deoxy-2’-
fluoroarabonucleic acid, 2’-F-ANA) (Fig. 3.8).  
 
Fig. 3.8. Comparison of nucleotide sugar conformation. Varying the atom composition 
and stereochemistry at the C2’ position of the ribose ring significantly impacts the ribose 
ring conformation. (a) Stereochemistry at the C2’ position of the nucleotides used in this 
study. (b) Preferred conformations of the ribose ring containing specified substitutions in 
polynucleotide contexts. Exo-conformations indicated by vertical lines connecting 
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functional groups at the indicated stereo-centers. Endo-conformations indicated by 
horizontal lines connecting functional groups.  
 
We assayed the binding of five-fold excess 2’-F-RNA containing substrate with 
A3Gctd-2K3A E259A (Fig. 3.9). Significant intensity changes were seen at residues 
R215, R238, N244, A246, L253, E254, R256, H257, L263, Q275, D276, W285NE, 
Y315, D316, G324, L325, T327, G355, and H367. The overall profile of the 2’-F-RNA 
containing oligomer displayed a binding profile intermediate to the RNA containing 
oligomer and the substrate 5’-CCU oligomer.  
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Fig. 3.9. A3Gctd-2K3A E259A binding fluorinated RNA mimic. (a) 1H-15N HSQC 
spectrum of 1mM 5’-AATCC(2’-F-RNA)CAAA : 0.2mM A3Gctd-2K3A E259A (red) 
overlaid onto 0.2mM A3Gctd-2K3A E259A (black) at pH 6.0. Spectra were acquired 
with 128 scans and 100 real points in the indirect dimension. Significantly shifted peaks 
labeled. (b) Quantification of peak intensity changes (gray bars, left axis) and chemical 
shifts (red bars, right axis). Significant changes in either peak intensity or chemical shift 
are indicated by colored residue names, cyan indicates core residue, red indicates surface 
residue. 
 
We then assayed the binding of five-fold excess 2’-F-ANA containing substrate 
with A3Gctd-2K3A E259A (Fig. 3.10). Binding of the 2’-F-ANA containing oligomer 
showed a combination of chemical shift perturbations and intensity changes similar to 
substrate oligomers with substantial reductions in intensity across the majority of the 
protein. Significant chemical shift perturbations were seen for residues H228, G251, 
G255, D264, W269NE, R313, and R326. Significant intensity changes were seen for 
residues N208, W211NE, R238, R239, G240, A246, L253, E254, R256, H257, A258, 
L263, D264, V265, W269NE, T283, W285NE, S306, A312, R313, Y315, G319, E323, 
L325, T327, L328, M338, T339, G355, D365, H367, and R376.  
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Fig. 3.10. A3Gctd-2K3A E259A binding to the 2’-F-ANA target cytidine substrate. 
(a) 1H-15N HSQC spectrum of 1mM 5’-AATCC(2’-F-ANA)CAAA : 0.2mM A3Gctd-
2K3A E259A (red) overlaid onto 0.2mM A3Gctd-2K3A E259A (black) at pH 6.0. 
Spectra were acquired with 128 scans and 100 real points in the indirect dimension. 
Significantly shifted peaks labeled. (b) Quantification of peak intensity changes (gray 
bars, left axis) and chemical shifts (red bars, right axis). Significant changes in either 
peak intensity or chemical shift are indicated by colored residue names, cyan indicates 
core residue, red indicates surface residue. 
 
3.3.7 Deamination of 2-F-RNA and 2-F-ANA containing substrates 
Following confirmation of 2’-F-RNA containing oligomer binding to A3Gctd-
2K3A E259A we then assayed the ability of the catalytically active A3Gctd-2K3A to 
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deaminate the potential substrate. We monitored deamination using real-time 1D 1H 
NMR, as previously described in [17], with a 30-fold excess of the fluorinated substrate 
looking for the presence of the characteristic H5 signal of uracil between 5.50 and 5.75 
ppm over the course of 8 hours (Fig. 3.11c). During the course of the experiment no 
uracil signals were observed confirming that the 2’-F-RNA cytidine base was effectively 
excluded from the catalytic site.  
We then performed the same 1D 1H deamination assay at 30-fold excess over 
A3Gctd-2K3A to determine if the 2’-F-ANA containing oligomer was a substrate. Over 
the course of 8 hours we observed the appearance of the H5 signal from the deaminated 
2’-F-ANA uracil product 5’-ATTCC(2’-F-ANA)UAATT at 5.58ppm followed by the 
appearance of the deamination product of the middle cytidine in the 5’-ATTCU(2’-F-
ANA)UAATT oligomer (Fig. 3.11d). The rate of deamination was dramatically reduced 
in the case of the 2’-F-ANA oligomer compared to the fully deoxyribose substrate (Fig. 
3.11a).  
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Fig. 3.11. Real-time NMR monitoring of substrate and potential substrate oligomer 
deamination. (a) 1D 1H spectra series of 0.15mM 5’-ATTCCCAATT : 0.0015mM 
A3Gctd-2K3A (deaminated cytidines underlined). 5’-CCU product doublet appears at 
5.64ppm, 5’-CUU product doublet appears at 5.735ppm with concurrent shifting of the 3’ 
uracil doublet to 5.66ppm. (b) 1D 1H spectra series of 0.15mM 5’-ATTCCrCAATT : 
0.05mM A3Gctd-2K3A. Spectrum of 5’-ATTCCrUAATT product (top) for reference. 
No deamination products were observed. (c) 1D 1H spectra series of 0.15mM 5’-
ATTCCrCAATT : 0.03mM A3Gctd-2K3A. No shifts in full 1D 1H spectrum were 
observed. (d) 1D 1H spectra series of 0.15mM 5’-ATTCC(2’-F-ANA)CAATT : 0.03mM 
A3Gctd-2K3A (deaminated cytidines underlined). 5’-CC(2’-F-ANA)U product doublet 
observed at 5.58ppm, 5’-CU(2’-F-ANA)U product doublet appears at 5.68ppm with 
concurrent shifting of the 3’ (2’-F-ANA) uracil to 5.60ppm.  
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3.4 Discussion 
 The C-terminal domain of APOBEC3G has been shown to deaminate cytidines in 
single stranded DNA with differing rates depending on target site context. APOBEC3G 
also possess the ability to selectively exclude ribonucleotides from deamination. The data 
presented in this study represent a comprehensive comparison of the structural 
interactions involved in discriminating between substrates as well as potential 
mechanisms for the rejection of ribonucleotides from catalytic binding. We have also 
presented the first data showing the full extent of ssDNA binding to both catalytically 
active A3Gctd-2K3A during active catalysis and inactive A3Gctd-2K3A E259A. The 
ssDNA binding interface of A3Gctd extends across the catalytic face of the protein 
engaging both the loops adjacent to the catalytic site as well as internal residues 
indicative of structural rearrangement upon binding. The structural rearrangement 
appears to require interactions distal from the active site in order to position the target 
base for catalysis consistent with APOBEC3G’s inability to deaminate single 
nucleosides.  
 A3Gctd-2K3A shows extensive perturbation across the protein upon DNA 
binding when compared to the more localized interactions of A3Gctd-2K3A E259A. As 
we have shown previously [17], A3Gctd completes deamination of the available high 
affinity 5’-CCC targets before beginning to deaminate the low affinity 5’-CCU targets. 
The likely cause of the observed protein-wide perturbation is conformational flexing 
between bound and unbound states present as the protein binds the initial 5’-CCC 
substrate and ejecting the deaminated 5’-CCU product to search for another high affinity 
5’-CCC substrate. This is consistent with A3G’s lack of processive deamination within 
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target sites containing multiple 5’-CC minimal substrate motifs. While A3Gctd-2K3A 
shows increased protein-wide perturbations the most significantly perturbed residues 
remain consistent with those seen in substrate binding to A3Gctd-2K3A E259A.  
 The generation of A3Gctd-2K3A E259A allowed us to identify the differences in 
substrate binding among differing target cytidine contexts without the convoluting effects 
of product release and subsequent product binding. Binding of the 5’-CCC substrate 
showed the highest apparent affinity of the substrates assayed with the most significant 
chemical shift perturbations across the binding interface. Similarly to the binding of 
A3Gctd-2K3A, A3Gctd-2K3A E259A bound to 5’-CCC displayed perturbations outside 
of the ssDNA binding interface indicative of structural rearrangement of the α2 and α3 
helices. Interestingly, perturbations are also present at the C-terminal end of the non-sheet 
region A234-R238 between the discontinuous β2 and β2’ sheet implying rearrangement 
of this region that persists into binding region 2 (BR2) containing the loop from residues 
A243-H257. These interactions likely help position the target cytidine in the active site as 
these perturbations are only present in the 5’-CCC and 5’-CCU substrates that are 
actively deaminated. The binding of 5’-CUU shows slightly higher than average 
perturbations at these positions but that lack of a target cytidine limits the extent. The 
primary region that differs between substrate and non-substrate oligomers is binding 
region 1 (BR1), specifically the alpha1 helix (T201-N207) and the following loop (N208-
T218). With the exceptions of W211NE and R215, which appear to be involved in all 
ssDNA interactions, these residues are perturbed extensively only in substrate oligomers. 
This is consistent with single alanine substitutions in this region preventing substrate 
deamination [29]. Perturbations of BR3 also appear to be intimately involved in the 
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discrimination between substrate and non-substrate oligomers. Residues W285NE and 
D316, similarly to W211NE and R215, are consistently perturbed upon all ssDNA 
binding. However, neighboring residues in binding region 3 (BR3) are only perturbed 
upon binding of target 5’-CC motifs. These perturbations extend to neighboring loop 
residues T311-G319 and also into the α4 helix. BR3 is structurally adjacent to BR1, 
further supporting this regions role in substrate discrimination. Interestingly, D365 which 
is conserved in 8 of the 11 APOBEC members [72] was only perturbed in oligomers 
containing a 5’-CC motif (including fluorinated substrates discussed later) indicating that 
this interaction is not exclusive to substrate binding but rather a more generalized di-
cytidine recognition. Taken together, residue W211NE, R215, W285NE, and D316 
constitute the minimal interaction interface required for non-specific ssDNA binding. 
Secondary interactions around these residues are responsible for high affinity ssDNA 
binding, substrate discrimination, and positioning of the target cytidine for catalysis.  
 
Fig. 3.12. Structural comparison of substrate and non-substrate binding interfaces. 
Significant perturbations (red) from substrate binding assays mapped onto A3Gctd (PDB 
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ID: 3V4K); 5’-AATCCCAAA (top left), 5’-AATCCUAAA (top right), and 5’-
AATCUUAAA (bottom) with surface residues labeled.   
 
APOBEC3G binds RNA to enable incorporation into budding HIV-1 virions [80], 
[95]–[97], yet excludes oligomers containing only a single RNA base at the 3’ target site 
from deamination [89]. To determine structural factors involved in DNA/RNA 
differentiation, we bound A3Gctd-2K3A E259A to oligomers containing RNA, 2’-F-
RNA, and 2’-F-ANA bases. Binding of 5’-CCrC to A3Gctd-2K3A E259A resulted in a 
pattern of perturbations similar to that seen in the 5’-CUU oligomer. We observed a 
slightly more extensive pattern of interaction with BR3 than seen in the non-substrate 
oligomer which is likely due to interactions between this region and the 5’-CC motif 
present in the 5’-CCrC pseudo target motif. 5’-CCrC binding lacked the characteristic 
BR1 interactions seen in substrate oligomers indicating that the presence of the ribose 
base inhibits access to the catalytic pocket and prevents the oligomer from assuming full 
catalytic binding.  
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Fig. 3.13. Structural comparison of ribose and fluorine modified oligomer binding. 
Significant perturbations (red) from substrate binding assays mapped onto A3Gctd (PDB 
ID: 3V4K); 5’-ATTCCCATT (top left), 5’-ATTCCrCAATT (top right), 5’-ATTCC(2’-F-
RNA)CAATT (bottom left), and 5’-ATTCC(2’-F-ANA)CAATT (bottom right) with 
surface residues labeled. 
 
Fluorinated nucleosides have been shown to have anti-viral and anti-cancer 
properties (reviewed in [98]). Fluorine serves as an isopolar and isosteric mimic of the 
native hydroxyl moiety in ribonucleosides, retaining similar interbond distances and the 
ability to be a hydrogen bond acceptor. For the purposes of this study we utilized 2’-F-
RNA and 2’-F-ANA to distinguish the mechanism of nucleotide exclusion from the 
catalytic site. The 5’-ATTCC(2’-F-RNA)CAATT oligomer retains the C3’-endo 
conformation of the un-substituted ribose base without being a hydrogen bond donor 
(Fig. 3.8). The 5’-ATTCC(2’-F-ANA)CAATT oligomer biases the base pucker towards 
the C2’-endo conformation typically seen in the ssDNA substrate while still retaining the 
strongly electronegative atom at the C2’ position to mimic the presence of an oxygen 
(Fig. 3.8). We observed an overall increase in perturbation upon binding to both 
fluorinated oligomers indicative of an increase in non-specific binding interactions. 
Binding to the non-substrate 2’-F-RNA oligomer displayed perturbations similar to 5’-
CCrC including minimal interaction with BR1. These results are consistent with the 
target 2’-F-RNA cytidine base assuming the C3’-endo conformation with little impact 
due to the loss of hydrogen bond donation as the mechanism of non-substrate gating. 
Comparatively, the substrate containing the 2-F’-ANA nucleotide engaged BR1 allowing 
for deamination of both the 2’-F-ANA cytidine as well as the subsequent deamination of 
middle deoxycytidine. While both of these substrates contain the highly electronegative 
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fluorine at their C2’, the propensity for 2’-F-ANA to assume the C2’-endo conformation 
of the native ssDNA allows for extensive interaction with the secondary binding residues 
and catalytic binding. Kohli and co-workers have suggested the importance of the C2’-
endo conformation for AID-catalyzed deamination using a substrate containing the 2’-F-
ANA modification in the target cytidine [90], and our result strongly support extending 
this hypothesis to APOBEC3G as the 2’-F-ANA did not prevent the catalytic binding, but 
2’-F-RNA did.  Therefore, we concluded that the ribose ring pucker of the target cytidine 
either allows, C2’-endo conformation, or excludes, C3’-endo conformation, the base from 
entering the catalytic pocket and/or assuming the catalytically active orientation.  
 
3.5 Methods summary 
3.5.1 Substrates 
Oligonucleotides containing standard DNA and RNA bases were synthesized by 
Integrated DNA Technologies. Oligonucleotides containing 2’-deoxy-2’-
fluororibonucleic acid and 2’-deoxy-2’-fluoroarabonucleic acid at the underlined position 
in the 5’-ATTCCCAATT oligonucleotide were synthesized by Boston Open Labs. 
 
3.5.2 Plasmid generation and protein purification 
A pGEX-6p-1 vector (GE Healthcare) containing the C-terminal catalytic domain of 
APOBEC3G, residues 191-384, with the previously reported 2K3A mutations (L234K, 
C243A, F310K, C321A, C356A) was used as the template for Quikchange mutagenesis 
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(Stratagene/Agilent Technologies). The resulting plasmid contained the catalytic domain 
with the addition of the E259A mutation. E. coli were transformed with plasmids 
containing either A3Gctd-2K3A or A3Gctd-2K3A E259A, grown to OD 0.5 at 37°C 
followed by a reduction in temperature to 17°C for 30 minutes, and protein expression 
was induced using a 0.1mM final concentration of IPTG. The cells were lysed using 
sonication into buffer containing 50mM sodium phosphate pH 7.3, 100mM NaCl, 2mM 
DTT, 0.002% Tween 20. Following high speed centrifugation the supernatant was bound 
to glutathione sepharose resin (GenScript) and washed under high salt/high detergent 
conditions, 400mM NaCl and 0.06% Tween 20, followed by two washes in low salt/low 
detergent conditions, 30mM NaCl and 0.002% Tween 20. The GST-tag was removed 
using PreScission protease (GE Healthcare) in 50mM sodium phosphate buffer at pH 7.3 
with 100mM NaCl, 2mM DTT, and 0.002% Tween 20. Following cleavage, the protein 
was dialyzed into sample buffer containing 50mM sodium phosphate pH 6.0, 100mM 
NaCl, 2mM DTT, 0.002% Tween 20, and 50µM ZnCl2.  
 
3.5.3 NMR assignment of A3Gctd-2K3A and A3Gctd-2K3A E259A 
All spectra were acquired on an 850MHz Bruker Ascend spectrometer equipped with a 
5mm Z-gradient TCI cryoprobe. Samples contained a final volume of 300µL (97% 
H2O/3% D2O, v/v), and spectra were taken at 293K. Backbone resonance assignments for 
the A3Gctd 2K3A E259A mutant were derived using TROSY versions of a standard set 
of triple resonance spectra (HNCA, HN(CO)CA, HNCACB, HN(CO)CACB, HNCO, 
HN(CA)CO) on uniformly 15N/13C labeled protein with 85% random deuteration at pH 
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7.3. Assignments were transferred to pH 6.0 HSQC spectra by titrating pH to identify 
relevant peak shifts. All spectra were processed using NMRPipe [99] and analyzed using 
SPARKY [100].  
 
3.5.4 Chemical shift perturbation analysis 
15N-HSQC substrate DNA titrations were collected on 0.2mM 15N-labelled A3Gctd-
2K3A or A3Gctd-2K3A E259A samples at pH 6.0 with unlabeled substrate ratios 
indicated. Each titration point was collected with 128 scans and 100 real data points in 
the indirect 15N  dimension. Chemical shift and intensity changes were monitored through 
a series of spectra at varying relative concentration ratios of 1:1, 1:2, 1:5 (A3Gctd-2K3A 
E259A:ssDNA). Chemical shift changes were calculated using the equation: 
 ∆𝛿𝑝𝑝𝑚 = √(𝛿𝐻𝑥 − 𝛿𝐻0)2 + (
𝛿𝑁𝑥−𝛿𝑁0
5
)
2
 
Intensity changes were calculated using the difference in peak height at the center of the 
15N-HSQC peak between the unbound and bound spectra divided by the unbound peak 
height.  
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Chapter 4  
Summary and Future Directions 
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 In this thesis, I have described a mechanism for the observed pH dependent 
effects on A3G’s affinity for substrate DNA. I have identified the A3G single stranded 
DNA binding interface during active catalysis. Furthermore, I have identified specific 
differences in the interaction interface between different deamination targets, substrate 
and non-substrate oligomers. By thoroughly characterizing the optimal conditions and 
substrates for specific binding to A3G, I have helped establish a foundation for further 
structural studies. Future experiments will be concentrated around solving the complex 
structure. Since the A3Gctd-2K3A E259A mutant displays strong, specific binding to 
substrate DNA, it is a good candidate for co-crystallization with single stranded DNA 
substrates. Incorporating this catalytically inactive C-terminal domain into a full length 
protein containing the recently solubilized N-terminal domain chimera protein [27] could 
allow for the first full-length A3G structure in complex with ssDNA. Utilizing the E59A 
mutant combined with the loop swap mutants previously characterized [16], might allow 
for the examination of TC target site binding to identify the residues involved in 
excluding this substrate from catalysis by A3G.  
 I have also identified a novel substrate for A3G in 2’-F-ANA cytidine and 
identified the ribose sugar pucker as the likely mechanism for RNA exclusion. Based on 
these results, further experiments utilizing ribose bases that exhibit the C2’-endo 
conformation should be conducted. Specifically, the introduction of an arabinose sugar 
containing the native hydroxyl at C2’ would solidify the sugar pucker hypothesis and 
exclude the hydroxyl gating hypothesis. Other non-native sugars, such as locked nucleic 
acids, might also yield interesting results and prove useful in formulating therapeutics 
targeting A3G.  
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